Log in

US FDA Expands Use Of Regeneron's Cholesterol Drug In Young Children

US FDA Expands Use Of Regeneron's Cholesterol Drug In Young Children
Description

The drug, Evkeeza, was approved in February 2021 as an additional treatment with other lipid-lowering therapies for patients aged 12 years and above with homozygous familial hypercholesterolemia (HoFH).

Erin Walker, public policy director of Montana child safety organization Project STAND, told NBC News McKenna spoke about the draft legislation, and she then raised the idea with politicians in her state.

March 22 (Reuters) - Regeneron Pharmaceuticals Inc said on Wednesday the U.S.
Food and Drug Administration had approved the expanded use of its drug in children aged 5 to 11 years to treat an ultra-rare disease that causes high cholesterol.

In the key northeastern region of Adamawa -- which could see the election of Nigeria's first woman governor -- the results were declared "inconclusive" as the number of voters unable to cast their ballot was greater than the margin between the two fro

TAIPEI, March 23 (Reuters) - Taiwan Foreign Minister Joseph Wu said on Thursday that President Tsai Ing-wen's meeting with U.S.
House Speaker Kevin McCarthy in the United States is still in the process of being arranged.

The states said the automakers had failed to take adequate steps to address the alarming rate of theft and urged them to accelerate the implementation of the software upgrade and provide free alternative protective measures for owners whose cars cannot support the software upgrade.

According to the results from Saturday's vote declared by the Independent National Electoral Commission (INEC), APC won the governorship in 15 states -- Lagos, Sokoto, Katsina, Jigawa, Gombe, Kwara, Niger, Yobe, Nasarawa, Cross River, Ebonyi, Ogun, Benue, Kaduna

The states filing the brief were California, Connecticut, Delaware, Hawaii, Illinois, Maryland, Massachusetts, Michigan, Minnesota, New Jersey, New Mexico, New York, Oregon, Pennsylvania, Rhode Island and Vermont.

The brief from the Caribbean governments, which was joined by a network of non-governmental organizations, follows a summit among regional leaders last month held in the Bahamas, where arms trafficking was a key topic.

Brief descriptionThe drug, Evkeeza, was approved in February 2021 as an additional treatment with other lipid-lowering therapies for patients aged 12 years and above with homozygous familial hypercholesterolemia (HoFH).

Group activity